Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826098 · ClinicalTrials.gov registry record · Phase 4
Platelet Rich Plasma (PRP) in Total Knee Replacement
A Phase 4 study, sponsored by Exactech.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00826098: Completed Phase 4 study, sponsored by Exactech.
NCT00826098 is a Phase 4 study that has completed, run by Exactech. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00826098, a Phase 4 study, has completed, sponsored by Exactech.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).
Primary Outcome
Hemoglobin level analysis
Interventions
- BIOLOGICAL Platelet Rich Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-02 |
| Phase | Phase 4 |
What the finished NCT00826098 record still lists
NCT00826098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Platelet Rich Plasma is the first listed.
NCT00826098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00826098 about?
NCT00826098 is a clinical study titled "Platelet Rich Plasma (PRP) in Total Knee Replacement". Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).
What is the current status of trial NCT00826098?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2008-12. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00826098?
The interventions under investigation include: Platelet Rich Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT00826098?
This trial is sponsored by Exactech, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00826098's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia